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Periodontitis is a chronic inflammatory disease affecting the soft and hard tissues
supporting the teeth, which often leads to tooth loss. Its significant impact on the patient’s
general health and quality of life point to a need for more effective management of
this condition. Existing treatments include scaling/root planning and surgical approaches
but their overall effects are relatively modest and restricted in application. The goal
of regenerative therapy of periodontal defects is to enhance endogenous progenitors
and thus promote optimal wound healing. Considering that the host or tissue might
be defective in the periodontitis context, it has been proposed that grafting exogenous
stem cells would produce new tissues and create a suitable microenvironment for tissue
regeneration. Thus, cell therapy of periodontium has been assessed in many animal
models and promising results have been reported. However, the methodological diversity
of these studies makes the conversion to clinical practice difficult. The aim of this review is
to highlight the primary requirements to be satisfied before the leap to clinical trials can be
made. We therefore review cell therapy applications for periodontal regeneration in animal
models and the concerns to be addressed before undertaking human experiments.
Keywords: mesenchymal stromal cells, periodontitis, tissue engineering, bone regeneration, clinical trials as topic
INTRODUCTION
Periodontitis is an immuno-infectious disease, characterized by
loss of both the soft and hard tissues anchoring the teeth.
Left untreated, it leads to tooth loss (Pihlstrom et al., 2005).
Chronic periodontitis is found in 15–50% of adults in devel-
oped countries (Oliver et al., 1998; Bourgeois et al., 2005).
Conventional treatment, including oral hygiene instructions, and
scaling/root planing, aims to prevent the disease, or slow or
stop its progress, and maintain the therapeutic goals achieved
but is usually insufficient to promote the regeneration of dam-
aged structures (Bosshardt and Sculean, 2009). Deep infrabony
defects associated with periodontal pockets are the classic indica-
tion for surgical periodontal regenerative therapy (Ramseier et al.,
2012). Nevertheless, outcomes of existing procedures [guided tis-
sue regeneration (GTR), Enamel-Matrix Derivatives (EMD) or
Platelet Rich Plasma (PRP)], are not predictable and are associ-
ated with a relatively high degree of variability (Needleman et al.,
2006; Esposito et al., 2009).
The regenerative mechanisms of mesenchymal stromal cell
(MSC) grafts include direct commitment toward differentiat-
ing cells together with paracrine communication with resident
connective cells, and infiltration of inflammatory cells, antigen-
presenting cells, or both (Sorrell and Caplan, 2010). Paracrine
interactions require these cells to produce and respond to a
variety of trophic factors that may stimulate the resident cells
to differentiate and themselves renew the pathological tissue
(Baraniak and McDevitt, 2010). In addition, MSCs also exhibit
immuno-modulatory functions, making them a potential tool
to combat an immuno-infectious disease such as periodontitis.
The reduction of inflammation by MSCs may halt the devel-
opment of injury and allow regenerative processes to take
place (Sensebe et al., 2010). Furthermore, MSCs may exert
a neovascularization effect (Wu et al., 2007). Thus, one of
the therapeutic functions of MSCs is the early induction of
granulation tissue followed by the stabilization of the neovas-
cular network in the periodontal niche (Sorrell and Caplan,
2010).
The graft of exogenous cells producing new tissues and/or
making the local microenvironment suitable for an optimal acti-
vation of in-situ progenitors (Ilic and Polak, 2012; Shin and
Peterson, 2013) has been tested in many models. Adult multipo-
tent mesenchymal stromal cells, from bone marrow (BMSCs) or
adipose tissue (adipose-derived stem cells or ASCs), are promis-
ing in the treatment of human diseases like graft-vs-host disease,
ischemic cardiovascular diseases or large bone defects (Bourin
et al., 2010; Sensebe et al., 2010). The main features of such cells
include a capacity to self-renew and to undergo extensive pro-
liferation and differentiation to various mesenchymal lineages
(Dominici et al., 2006). Considering that the host or tissue might
be defective in the periodontitis context, grafting exogenous
MSCs that produce new tissues and create a suitable microenvi-
ronment for tissue regeneration has been proposed (Chen et al.,
2012a). However, the methodological diversity of the available
studies makes the conversion to clinical practice difficult. The aim
of this review is, first, to report recent findings of periodontal
regeneration in animal models and, second, to highlight the pri-
mary requirements to be satisfied before the leap to clinical trials
can be made.
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RESULTS FROM ANIMAL STUDIES
Advances in mesenchymal stem cell isolation, growth factor biol-
ogy, and biodegradable polymer constructs have set the stage for
successful tissue engineering of the periodontium, basically in
animal models. Our screening of the literature revealed that data
were available for about fifty studies. The majority of them con-
cerned periodontal defects generatedmechanically (burs) on dogs
and rodents. Except for nude rodents where xenogeneic cells were
used, most studies used autologous cell grafts. Periodontal lig-
ament stromal cells (PDLSCs) were employed in about half the
studies.
Table 1 outlines the general methodology from recent papers
investigating periodontal regeneration of various defect models
in a range of large animals. These studies were selected both
for their methodological quality and to reflect the heterogeneity
of methodologies used. We voluntarily did not select studies on
rodents because of the low similarity between their physiopathol-
ogy and that of humans, although they are considered as essential
models for preliminary protocols before moving on to large-
animal trials. Overall, the outcomes reported (Table 2) suggest
that MSCs have the ability to enhance the regeneration of func-
tional periodontal apparatus: newly formed bone and cementum
with well-oriented ligament fibers.
RESULTS FROM HUMAN STUDIES
We identified 7 case reports (for a total of 22 patients) where
MSCs had been applied clinically for infra-bony defects and fur-
cation involvement after chronic periodontitis in humans. The
efficacy of human periodontal cell therapy by grafting autolo-
gous stromal cells from gingiva or periodontal ligament with a
hydroxyapatite (HA) carrier has been assessed since 1992 (Feng
andHou, 1992; Feng et al., 1995, 2010; Hou et al., 2003). Cultured
mandibular periosteum-derived cell sheets with PRP have also
been used in the treatment of chronic periodontitis without
(Mizuno et al., 2010) or with HA in patients suffering from
advanced chronic periodontitis (Okuda et al., 2009). A BMSC-
PRP gel has also been used in an infrabony periodontal defect
and led to a 4mm clinical attachment gain (Yamada et al., 2006).
Results suggest promising improvements in pocket depth, attach-
ment gain and tooth mobility, compared to control groups when
present. These data suggest MSCs may induce efficient and safe
periodontal regeneration in humans.
Through the International Clinical Trials Registry Platform
(World Health Organization), we identified four clinical studies
(last access 2013/08/27): two single-arm studies using (i) ASCs
for 12 patients with deep infra-bony defects (recruiting) and
(ii) a mixture of ex-vivo cultured MSCs and ex-vivo cultured
osteoblast-like cells differentiated from MSCs for 10 patients
with chronic periodontitis (completed); and two trials investigat-
ing the safety and efficacy of PDLSCs in chronic periodontitis,
one randomized and one non-randomized controlled trial, with
respectively 35 and 80 patients (recruiting).
Nevertheless, results from case reports and clinical trials
should be interpreted with caution. Although the clinical poten-
tial of MSCs in tissue regeneration appears to be established,
the mechanisms involved in these processes after transplantation
are not clearly understood (Chen et al., 2012b; Hoogduijn and
Dor, 2013). Moreover, the clinical indications in periodontology
remain be defined (Chen and Jin, 2010); themultiplicity of factors
to be taken into account makes the regeneration equation more
complex. Future studies should discuss regeneration according
to the type of periodontal defects (number of walls), the type of
periodontitis (chronic, aggressive) or themethod used to generate
the periodontitis model in animals, whether the MSCs are autol-
ogous, allogeneic or xenogeneic, the type of animal (dog, pig),
the source tissue of MSCs (dental, oral, or extra-oral sources),
the scaffold used, adjunctive growth factors or specific culture
medium, etc.
KEY ELEMENTS TO CONSIDER BEFORE MAKING THE STEP
TO CLINICAL TRIALS
The transfer of pre-clinical data to the clinical setting could be
challenging and time consuming. So we will discuss some ele-
ments related to the choice of the origin of MSCs, their potential
toxicity and their carrier, some laboratory considerations, the
extent to which animal models reflect the applicability of the
technique in humans, and regulatory information.
CELL SOURCES
One of the most important items of information that could help
with the predictability of clinical results is the type of cell used. On
the one hand, each tissue source has its own biological features
and, even when they have common surface markers, these cells
are determined by their original environment and may possibly
be involved in specific differentiation pathways (Lin et al., 2009).
On the other hand, the local microenvironment and surrounding
tissue are important factors that influence the cell fate of whatever
cells are ultimately used (Chen et al., 2011).
As stated above, PDLSCs are the cells most used for clinical tri-
als, probably because of their periodontal origin and promising
results in both animal and human trials (Feng et al., 2010; Suaid
et al., 2012). Even if the choice of stromal cells from the oral niche
(pulp, ligament, gingiva or oral alveolar bone) seems rational
when the aim is to regenerate periodontal structures (Lin et al.,
2009), periodontitis defects need a large number of cells (about
107 cells are needed for one defect), which would be impossible to
obtain from a single subject. Thus, the respect of ethical consider-
ations (e.g., putative removal of healthy teeth, increasing genetic
instability through passages during cellular expansion) requires
other sources of MSCs to be sought.
Two major locations of available MSCs are long-bone mar-
row and adipose tissue. These cells are morphologically and
immunophenotypically similar to PDLSCs (Huang et al., 2009).
Unlike BMSCs, ASCs can be recovered easily in large numbers
by means of liposuction under local anesthesia. Indeed, adi-
pose tissue is the richest source of MSCs, 100 times more than
bone marrow (Bourin et al., 2010). Although ASCs may exhibit
a reduced ability to differentiate into bone and cartilage (Kern
et al., 2006) compared to BMSC or oral mesenchymal cells, they
have given promising results in periodontal regeneration in dogs
(Takedachi et al., 2013; Tobita et al., 2013).
The need for high cell concentrations requires the optimal
type of transplant to be determined. To become a clinical real-
ity, xenografts need to overcome immunological, physiological,
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and infectious obstacles (Poncelet et al., 2009). For example, the
donor might be genetically modified to protect its cells from
the human immune system (Li et al., 2012). MSCs are both
immunosuppressive and immunoprivileged and, as such, may be
used as an allogeneic source of cells. A recent randomized con-
trolled trial showed significant benefits and low rates of immuno-
logic reactions for transendocardial injection of allogenic BMSCs
in patients with ischemic cardiomyopathy (Hare et al., 2012).
Another limitation is the time required to produce theMSCs. Cell
storage may be used to provide enough material at the time of
graft. In a beagle dog, cryopreservation of BMSCs did not alter
the periodontal regeneration compared to the use of non-stored
cells (Li et al., 2009). However, additional studies are required to
ensure the safety of allogenic grafts and cell cryopreservation.
ADVERSE EFFECTS
With population doublings during the expansion stage, MSCs
may be subject to senescence and genetic instability. Progressive
shortening of telomeres, modified telomeric structures, and acti-
vation of the retinoblastoma protein (pRB) or p53 pathways
have been demonstrated to be important triggers for replica-
tive senescence (Schellenberg et al., 2011). Basically, the role of
MSCs in cancer can be divided into indirect involvement via the
tumor modulatory effect and direct involvement via malignant
transformation of themselves (Wong, 2011). The “homing” effect
allows MSCs to migrate toward tumor cells, interact with the
stroma, and enhance its growth (Wong, 2011). Also, it can lead
to malignant transformation of MSCs at the tumor site. While
the immunosuppressive properties of MSCs are a good tool for
immune disorders, a suppressed immune system may encour-
age tumor growth in patients with cancer (Shinagawa et al.,
2010). To date, no malignant formation has been reported during
the course of clinical studies involving periodontal cell therapies
(Giordano et al., 2007; Yoshida et al., 2012). Moreover, PDLSC
did not induce tumorigenesis after injection into immunodefi-
cient mice for at least 12 weeks (Washio et al., 2010). However,
improvements in the understanding of genetic and epigenetic
changes will enable researchers to address the risk of tumorige-
nesis in the context of each type of cell transplantation therapy.
CELL CULTURE DURING LABORATORY PHASES
The definition of MSCs as advanced-therapy medicinal prod-
ucts in European regulations and the US Food and Drug
Administration requirements implies the use of production pro-
cesses in accordance with GoodManufacturing Practices (GMPs).
Requirements concern the environment, staff training and qual-
ification, and controls (Sensebe et al., 2013). Culture conditions
are not sufficiently developed to mimic the in-vivo cell microenvi-
ronment and to ensure that cell proliferation and differentiation
can be performed safely (van der Sanden et al., 2010).
Cell culture status, such as culture medium composition
and oxygen supply, may interact with MSC expansion and ex-
vivo properties. Even though they are extensively described in
studies, there is no consensus about the required culture con-
ditions. Nevertheless, fetal calf serum (FCS), often used as
a supplement, contains a xenogeneic source of growth fac-
tors and may transmit animal pathogens (Bourin et al., 2010).
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Table 2 | Results from animal studies.
References Experimental group outcomes Control group outcomes Conclusion
Akizuki et al.,
J. Periodontal. Res., 2005
Periodontal tissue healing with bone,
cementum, and periodontal ligament
formation was observed in three
defects. Signs of ankylosis were
observed in some specimens.
No cementum was formed, only one
defect showed new bone. Parallel
connective tissue existed adjacent to
the denuded root surface.
The periodontal ligament cell sheet
applied in a dehiscence-type defect
resulted in regeneration of periodontal
tissues in beagle dogs.
Chen et al., Gene Ther.,
2008
BMP-2 gene-infected BMSCs
Newly formed periodontal ligament
fibers were functionally orientated
and new connective tissue fibers had
been inserted into both the new
cementum and the new bone.
BMSCs
Woven bone was formed from apical
part of defects to middle of the roots.
There were small resorption areas
with new cementum and fibers.
Regeneration of the periodontal
attachment apparatus was enhanced
by cells engineered to express BMP-2
gene.
Ding et al., Stem Cells,
2010
Both the autologous and allogeneic
PDLSC treatments significantly
improved periodontal tissue
regeneration compared with the
HA/TCP and control groups.
New bone, cementum, and
periodontal ligament were
regenerated to normal levels in both
the autologous and allogeneic PDLSC
groups.
Limited or partial periodontal tissue
regeneration in the control groups and
HA/TCP group.
Little alveolar bone recovery.
A sheet of minipig PDLSCs can repair
allogeneic bone defects in an
experimental model of periodontitis.
Fawzy El-Sayed et al.,
J. Clin. Periodontol., 2012
Higher clinical attachment level,
probing depth and lower gingival
recession. Thin multi-layered
squamous sulcular epithelium.
Regeneration of bone, cementum,
and periodontal ligament with
Sharpey’s fibers similar to normal
periodontium.
Higher histological attachment level,
lower junctional epithelium length,
and connective tissue adhesion.
Thicker multi-layered squamous
sulcular epithelium.
Periodontal tissue loss, unorganized
Sharpey’s fibers, root resorption, and
ankylosis.
Gingival margin-derived
stem/progenitor cells show significant
periodontal regenerative potential.
Hasegawa et al.,
J. Periodontol., 2006
New cementum.
New regenerated periodontal
ligament separating the new bone
from the cementum.
No complete alveolar bone
reconstruction.
Insufficient periodontal regeneration.
Epithelial cells invading top of the
furcation, and no cementum
regeneration.
Transplanted BMSCs can survive and
differentiate into periodontal
tissue–composing cells, resulting in
enhancement of periodontal tissue
regeneration.
Iwata et al., Biomaterials,
2009
Complete bone filling with an
appropriate space of periodontal
ligament was observed.
Complete periodontal regeneration
with both newly formed bone and
cementum connecting with
well-oriented collagen fibers.
Almost 50% of bone filling was
observed.
Transplantable multi-layered PDLSC
cell sheets were successfully
fabricated and induced a true
periodontal system, including alveolar
bone, cementum, and well-oriented
fibers at the same time.
Li et al., Cells Tissues
Organs, 2009
Both cryo- and non-cryopreserved
BMSC groups exhibited periodontal
regeneration. New PDL was formed
between the new alveolar bone and
cementum with Sharpey’s fibers
extending into the newly formed
cementum and bone. Cementum and
PDL were fully regenerated.
Very little regenerated alveolar bone
and cementum.
PDL fibers were parallel to the root
surface. Small lacunae of resorption
were present on roots.
Cryopreserved BMSCs showed no
altered regenerative capacity
compared with freshly isolated
BMSCs in the application of
periodontal regeneration.
(Continued)
Frontiers in Physiology | Craniofacial Biology November 2013 | Volume 4 | Article 325 | 6
Trofin et al. Cell therapy of periodontium
Table 2 | Continued
References Experimental group outcomes Control group outcomes Conclusion
Liu et al., Stem Cells,
2008
New bone and periodontal tissues
were regenerated with newly formed
Sharpey’s fibers anchored into the
newly regenerated cementum.
Nevertheless, bone was not
regenerated to normal level.
Fibers lacking the typical structure of
Sharpey’s fibers filled in the
periodontal defect. Residual
inflammation was still present.
The study demonstrated the utility of
using an autologous PDLSC
therapeutic approach to treat
periodontitis in a miniature pig
preclinical model.
Nunez et al.,
J. Periodontal. Res., 2012
Histological characteristics of
periodontal regeneration: formation of
new cellular cementum, no signs of
root resorption or ankylosis, rich
capillary vessels.
Greater new-bone formation in the
PDLDC group.
Healing by repair, with limited
formation of new cellular cementum.
No signs of root resorption or
ankylosis.
Cellular therapy, in combination with a
collagen sponge, promoted
periodontal regeneration in
experimental infra-bony periodontal
defects.
Park et al., Cell
Transplant., 2011
Healing response was favorable for all
treatment groups. For PDLSC group,
incremental lines of neocementum
were observed, with Sharpey’s fibers
inserted and cellular cementum at the
root apex.
No tissue attachment but presence of
surrounding granulation.
PDLSCs may significantly promote
periodontal regeneration in class II
furcation defects in dogs. Authors
suggested PDLSCs were the best
candidates for regeneration.
Simsek et al., Clin. Oral
Investig., 2012
Formation of new cementum and
coronal growth of alveolar bone were
observed in all groups. No root
resorption or ankylosis was present.
No efficacy difference between the
groups was found for alveolar bone
formation. There was no severe
inflammation or swelling and
dehiscence of the flaps.
Regeneration of cementum for cell
group was significantly higher than
control group.
Periodontal regeneration with
complete filling of class II furcation
defects with cementum, alveolar
bone, and periodontal ligament was
obtained for all groups compared to
control group.
Suaid et al., J. Clin.
Periodontol., 2011
Woven bone was predominant. In all
groups, new cementum and obliquely
oriented periodontal fibers were
regenerated. Ankylosis was present in
one specimen for each group.
Nevertheless, cell group presented
more new cementum surface, less
connective tissue and epithelium
along root surface, more bone area
than control group.
Large bone marrow spaces were
predominant. Down-growth of
epithelium was observed in some
histological sections.
PDLSCs with guided tissue
regeneration were shown to be
efficient for periodontal regeneration
in class II furcation defects.
Suaid et al., J. Clin.
Periodontol., 2012
Cell-treated group exhibited larger
area of new bone, more cementum,
and more periodontal regeneration
than other groups. Complete filling of
the furcation was achieved in 2 out of
6 defects.
All defects showed gingival recession
with exposure of the furcation area.
Defects were incompletely filled, with
inflamed connective tissue covered by
gingival epithelium. There was no
cementum covering entire root area.
PDLSCs in association with guided
tissue regeneration may significantly
promote periodontal regeneration in
class III furcation defects surgically
created in dogs.
Takedachi et al., J. Oral
Biosci., 2013
Compared to control, bone mineral
density increased in 2-wall defects.
New bone and new cementum were
formed, with connective tissue fibers
inserted vertically in the furcation
class II defect.
A mix of ASCs and fibrin gel promoted
periodontal regeneration in beagle
dogs.
(Continued)
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Table 2 | Continued
References Experimental group outcomes Control group outcomes Conclusion
Tobita et al., Cytotherapy,
2013
New bone was formed and
periodontal complex was regenerated
after 2 months. Osteocalcin-positive
cells were found on the surface of the
dentin.
Ingrowth of epithelium into the defect
was found in the non-implanted
group. Granular tissue and
radiolucency were observed in both
control groups.
Efficacy of the combination of ASCs
and PRP in canine periodontal tissue
regeneration.
Tsumanuma et al.,
Biomaterials, 2011
PDLSC group showed more cellular
and acellular cementum than other
groups. Dense collagen fibers were
perpendicularly attached to the
cementum-like tissue layer. In BMSC
group, fibers were obliquely oriented
whereas they were parallel in APC
group.
Collagen fibers were sparse.
Alveolar bone regeneration was
observed in all groups.
PDLSC sheets combined with β-TCP
and collagen induced more
periodontal regeneration than in other
groups.
Abbreviations: ASC, adipose-derived stem cell; BMP2, bone morphogenetic protein-2; BMSC, bone marrow stromal cell; HA, hydroxyapatite; PDL, periodontal
ligament; PDLSC, periodontal ligament stromal cell; TCP, tricalcium phosphate.
Addition of human blood-derived products to replace FCS
is secured by serologic and nuclear acid testing for blood-
transmitted viruses. Human platelet lysate, a blood plasma
enriched in platelet growth factors released by freezing-thawing
cycles, may be used to produce clinical-grade, stem-cell-loaded
biomaterials as an appropriate FCS substitute in line with clin-
ically applicable practice (Warnke et al., 2013). Various other
serum-free media based on mixtures of defined growth fac-
tors are also able to maintain the main phenotypic and func-
tional characteristics of cultured MSCs (Chase et al., 2010) but
are restricted to research purposes and require upgrading for
clinical uses.
USE OF CARRIER AND GROWTH FACTORS
In the review of the literature on periodontal regeneration by
MSCs, one of the most striking elements is the numerous car-
riers that have been used. Cortical bone particulates (Simsek
et al., 2012), bovine bone (Fawzy El-Sayed et al., 2012), HA
(Ding et al., 2010), polymers (Park et al., 2012), collagen (Suaid
et al., 2011), hydrogel (Wei et al., 2010), gelatin (Yang et al.,
2010), fibrinogen/thrombin (Hynes et al., 2013), PRP (Tobita
et al., 2013), cells as sheets (Tsumanuma et al., 2011), alone or
in combination, have been suggested to help cell grafting. The
heterogeneity among study methodologies makes it difficult to
compare them and to draw sound conclusions. Biomolecules, in
particular growth factors, have been suggested for addition to
scaffolds to enhance periodontal regeneration (Saito et al., 2009).
It has been reported that modified MSCs overexpressing growth
factors such as BMP-2 (Chen et al., 2008; Chung et al., 2011) or
bFGF (Tan et al., 2009) could improve the healing of periodontal
defects by maintaining a long-term release of these factors in situ
(Ramseier et al., 2012).
PERIODONTITIS MODELS IN ANIMALS
Non-human primates are similar to humans, with comparable
periodontal tissue structures. However, most non-human pri-
mates used for research purposes are expensive and difficult
to handle, and ethical restrictions apply to their exploitation
(Struillou et al., 2010). The beagle is one of the most com-
monly used due to its size and its cooperative temperament
(Haney et al., 1995; Struillou et al., 2010). Minipigs are also an
alternative (Fawzy El-Sayed et al., 2012). However, animal mod-
els are unable to mimic some fundamental features: the spon-
taneous emergence of disease (even though some periodontal
lesions can occur in aged animals, periodontal defects are mostly
mechanically generated), genetic background, and risk factors
(aggressive bacterial flora, occlusal overload, tobacco, prosthesis,
systemic diseases of host, and donor, etc.). Overall, these features
should be investigated when clinical trials are being designed and
analyzed.
REGULATORY INFORMATION
The translation of a cell-based therapy from bench to bedside
is challenging, in a regulatory framework involving multiple
responsible authorities. Japan, Europe, and the United States
have developed quality standards to regulate cell based therapies
with Good Clinical Practice and GMP (Yoshida et al., 2012). In
the USA, MSCs are considered in the context of “361 Human
Cells, Tissues, or Cellular and Tissue-Based Products” (source:
www.fda.gov). For European countries, the framework for human
trials is fixed by regulation number 1394/2007 on advanced
therapy medicinal products, in force since December 2008.
The clinical development plan should start with the submis-
sion of a clinical trial authorization application to the competent
authority; clinical trials should be designed to demonstrate the
safety and efficacy of cells (George, 2011). It can be noted that, in
2006, the WHO stated that all clinical trials should be registered.
Moreover, US federal law (Food and Drug Administration) rec-
ommends the registration of trials via clinicaltrials.gov to record
key elements of study and basic results, and to report adverse
events (Califf et al., 2012).
In first-in-man studies, specific safety endpoints may need to
be defined to explore: cross-contamination in cases of allogeneic
and xenogeneic graft, chromosomal stability, contamination with
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microorganisms, safety of engineering devices, stemness poten-
tial, functional characterization, and cell phenotype (Dittmar
et al., 2010). Because of the risk-benefit balance in periodontal
regeneration, emphasis should be placed on the safety of these
therapeutics.
CONCLUSION
Animal studies suggest that mesenchymal stem cells are effective
and safe for periodontal regeneration. Nevertheless, additional
studies are needed to improve periodontal cell therapy regenera-
tion and to decipher the biological mechanisms that are involved.
For example, a recent study in dogs suggested that periodon-
tal regeneration could be obtained with stem-cell conditioned
medium, possibly thanks to multiple cytokines (Inukai et al.,
2013). To materialize the translation of cell therapy from the
laboratory to the dental chair a compromise, providing real ben-
efits for patients, respecting biosafety requirements, available at
affordable prices, covered by a social security system and suffi-
ciently attractive to encourage industrial companies to invest in
its development, is still required. It is possible that cell therapy
will be implemented in clinical practice as a routine technique in
the future.
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